In addition, GenAssist is advancing other Duchenne muscular dystrophy exon-skipping programmes, which cover more than 30 per cent Duchenne muscular dystrophy population.” GEN6050X injection is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results